Aptevo Therapeutics Inc. (APVO)
Track the next or latest earnings date for Aptevo Therapeutics Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
www.stocktitan.net · 1 week ago
The CARE Fund grant supports APVO451 IND-enabling work, with development candidate selection targeted by year-end 2026 and IND studies in Q1 2027.
Aptevo receives $1.5M grant for cancer therapy development By Investing.comwww.investing.com · 1 week ago
APVO451 incorporates Aptevo’s CRIS-7-derived CD3 binding domain, the same CD3 platform approach used in mipletamig, the company’s lead clinical program. The program is part of Aptevo’s pipeline of multispecific immunotherapies. While the stock has declined 92% over the past year, InvestingPro ...
Aptevo Therapeutics Secures Grant for APVO451 Development - TipRanks.comwww.tipranks.com · 1 week ago
Aptevo Therapeutics ( ($APVO) ) has shared an update. On June 29, 2026, Aptevo Therapeutics entered a Grant Award Agreement with the Andy Hill Cancer Research Endow...
American Electric Power’s Quarterly Earnings Preview: What You Need to Knowbarchart.com · 1 day ago
American Electric Power is scheduled to release second-quarter results later this month, and analysts predict a single-digit growth in the company’s bottom-line figure.
AeroVironment Posted Solid Earnings and the Stock Reacted Sharply Higher. If You Can Tolerate Risk, Buy Here.barchart.com · 3 days ago
AeroVironment shares jumped 18.76% after posting strong fiscal Q1 2026 results with revenue of $641.6 million and an adjusted EPS beat.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: -$8.09
Revenue estimate: N/A
Market cap: $3.55M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Mar 20, 2026 | 2025-12-31 | Time not specified | -$8.09 | N/A |
| Feb 13, 2026 | Dec/2025 | Time not specified | -$8.09 | N/A |